RESEARCH teams at the South Australian Health and Medical Research Institute (SAHMRI) have announced they will be trialling an innovative in vitro platform to study live brain cells directly from Parkinson's patients, rather than using classical animal models.
This new research strategy emerged from a recent Nobel Prize discovery about reprogramming stem cells - CLICK HERE for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Sep 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Sep 17
